Introduction: Bronchopulmonary sequestration (BPS), a rare congenital pulmonary malformation, is characterized by nonfunctional pulmonary parenchyma with aberrant systemic arterial supply (typically from the aorta or its major branches) and absence of communication with the tracheobronchial tree. Large BPS lesions pose significant fetal risks, including hydrops fetalis, mediastinal shift, and polyhydramnios, necessitating timely prenatal intervention to prevent fetal demise.
Case presentation: We present a case of successful ultrasound-guided radiofrequency ablation (RFA) of the feeding artery in a fetus diagnosed with BPS at 22 weeks of gestation. Under ultrasound guidance, a 17-gauge RFA needle was percutaneously inserted into the aberrant feeding artery, achieving complete vascular occlusion without procedural complications. Serial prenatal ultrasounds demonstrated progressive lesion involution. The pregnancy was complicated by cephalopelvic disproportion (CPD), prompting cesarean delivery at 38 weeks. Neonatal computed tomography (CT) confirmed shrinkage of the residual sequestration tissue. Six-month postnatal follow-up revealed normal respiratory function, age-appropriate growth, and developmental milestones.
Conclusion: RFA represents a safe and effective minimally invasive prenatal therapy for BPS. Candidate selection requires comprehensive evaluation of fetal hydrops, lesion size, gestational age, and parental preferences. Amniotic fluid sampling during the procedure is advisable for genetic/ancillary testing. This case highlights the utility of RFA in optimizing fetal outcomes while avoiding open neonatal period surgery. Long-term neonatal follow-up supports the durability of vascular occlusion and functional recovery.
{"title":"Prenatal radiofrequency ablation for bronchopulmonary sequestration: a case report of successful fetal intervention and longitudinal outcomes.","authors":"Hui Xi, Huilin Su, Zheming Jiang, GuiJun Li, Yingchun Luo, Yabing Tang, Huiping Zhang, Dandan Ling","doi":"10.1080/14767058.2026.2640647","DOIUrl":"https://doi.org/10.1080/14767058.2026.2640647","url":null,"abstract":"<p><strong>Introduction: </strong>Bronchopulmonary sequestration (BPS), a rare congenital pulmonary malformation, is characterized by nonfunctional pulmonary parenchyma with aberrant systemic arterial supply (typically from the aorta or its major branches) and absence of communication with the tracheobronchial tree. Large BPS lesions pose significant fetal risks, including hydrops fetalis, mediastinal shift, and polyhydramnios, necessitating timely prenatal intervention to prevent fetal demise.</p><p><strong>Case presentation: </strong>We present a case of successful ultrasound-guided radiofrequency ablation (RFA) of the feeding artery in a fetus diagnosed with BPS at 22 weeks of gestation. Under ultrasound guidance, a 17-gauge RFA needle was percutaneously inserted into the aberrant feeding artery, achieving complete vascular occlusion without procedural complications. Serial prenatal ultrasounds demonstrated progressive lesion involution. The pregnancy was complicated by cephalopelvic disproportion (CPD), prompting cesarean delivery at 38 weeks. Neonatal computed tomography (CT) confirmed shrinkage of the residual sequestration tissue. Six-month postnatal follow-up revealed normal respiratory function, age-appropriate growth, and developmental milestones.</p><p><strong>Conclusion: </strong>RFA represents a safe and effective minimally invasive prenatal therapy for BPS. Candidate selection requires comprehensive evaluation of fetal hydrops, lesion size, gestational age, and parental preferences. Amniotic fluid sampling during the procedure is advisable for genetic/ancillary testing. This case highlights the utility of RFA in optimizing fetal outcomes while avoiding open neonatal period surgery. Long-term neonatal follow-up supports the durability of vascular occlusion and functional recovery.</p>","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"39 1","pages":"2640647"},"PeriodicalIF":1.6,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147482148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-12-01Epub Date: 2026-03-26DOI: 10.1080/14767058.2026.2638630
Jie Liu, Nana Yang, Miao Zhang, Suqin Zhang
Objectives: To investigate the predictive performance of the second-trimester soluble fms-like tyrosine kinase-1/placental growth factor (sFlt-1/PlGF) ratio for composite adverse neonatal outcome (CANO) in preeclampsia (PE).
Methods: This retrospective cohort study enrolled 253 PE women during June 2022-June 2024. Maternal serum levels of sFlt-1 and PlGF were assessed, and their ratio was determined at 13-27 gestational weeks. Subjects were stratified into CANO (n = 80) and non-CANO (n = 173) groups. Baseline characteristics and the sFlt-1/PlGF ratio were compared. Univariate and multivariate logistic regression analyses were employed to identify independent risk factors for CANO. Predictive value was assessed using ROC curve analysis, and a nomogram prediction model was constructed.
Results: The sFlt-1/PlGF ratio was markedly higher in the CANO group than the non-CANO group (p < 0.001). Multivariate analysis identified the sFlt-1/PlGF ratio (OR = 1.040, 95% CI: 1.020-1.060, p < 0.001), serum uric acid level (OR = 1.007, 95% CI: 1.000-1.013, p = 0.043), and history of pre-pregnancy hypertension (OR = 13.51, 95% CI: 2.065-88.36, p = 0.007) as independent risk factors for CANO. Conversely, gestational age at delivery (OR = 0.727, 95% CI: 0.621-0.852, p < 0.001) was a protective factor. The sFlt-1/PlGF ratio predicted CANO with an AUC of 0.799 (95% CI: 0.743-0.855). The integrated nomogram model achieved a C-index of 0.880 (95% CI: 0.836-0.923), indicating excellent discrimination.
Conclusion: The second-trimester sFlt-1/PlGF ratio is an independent predictor for CANO in PE. A model incorporating this biomarker facilitates the early identification of high-risk neonates, informing personalized perinatal management.
目的:探讨妊娠中期可溶性膜样酪氨酸激酶-1/胎盘生长因子(sFlt-1/PlGF)比值对子痫前期(PE)复合新生儿不良结局(CANO)的预测作用。方法:这项回顾性队列研究于2022年6月至2024年6月期间招募了253名PE女性。评估母体血清sFlt-1和PlGF水平,并在妊娠13-27周测定其比值。将受试者分为CANO组(n = 80)和非CANO组(n = 173)。比较基线特征和sFlt-1/PlGF比值。采用单因素和多因素logistic回归分析确定CANO的独立危险因素。采用ROC曲线分析评估预测价值,并建立nomogram预测模型。结果:CANO组sFlt-1/PlGF比值明显高于非CANO组(p OR = 1.040, 95% CI: 1.020 ~ 1.060, p OR = 1.007, 95% CI: 1.000 ~ 1.013, p = 0.043),且孕前高血压史(OR = 13.51, 95% CI: 2.065 ~ 88.36, p = 0.007)为CANO的独立危险因素。相反,分娩时胎龄(OR = 0.727, 95% CI: 0.621-0.852, p CI: 0.743-0.855)。综合模态图模型的c指数为0.880 (95% CI: 0.836-0.923),判别性良好。结论:妊娠中期sFlt-1/PlGF比值是PE CANO的独立预测因子。纳入该生物标志物的模型有助于早期识别高危新生儿,为个性化围产期管理提供信息。
{"title":"Association between second-trimester sFlt-1/PlGF ratio and composite adverse neonatal outcome in patients with preeclampsia.","authors":"Jie Liu, Nana Yang, Miao Zhang, Suqin Zhang","doi":"10.1080/14767058.2026.2638630","DOIUrl":"https://doi.org/10.1080/14767058.2026.2638630","url":null,"abstract":"<p><strong>Objectives: </strong>To investigate the predictive performance of the second-trimester soluble fms-like tyrosine kinase-1/placental growth factor (sFlt-1/PlGF) ratio for composite adverse neonatal outcome (CANO) in preeclampsia (PE).</p><p><strong>Methods: </strong>This retrospective cohort study enrolled 253 PE women during June 2022-June 2024. Maternal serum levels of sFlt-1 and PlGF were assessed, and their ratio was determined at 13-27 gestational weeks. Subjects were stratified into CANO (<i>n</i> = 80) and non-CANO (<i>n</i> = 173) groups. Baseline characteristics and the sFlt-1/PlGF ratio were compared. Univariate and multivariate logistic regression analyses were employed to identify independent risk factors for CANO. Predictive value was assessed using ROC curve analysis, and a nomogram prediction model was constructed.</p><p><strong>Results: </strong>The sFlt-1/PlGF ratio was markedly higher in the CANO group than the non-CANO group (<i>p</i> < 0.001). Multivariate analysis identified the sFlt-1/PlGF ratio (<i>OR</i> = 1.040, 95% <i>CI</i>: 1.020-1.060, <i>p</i> < 0.001), serum uric acid level (<i>OR</i> = 1.007, 95% <i>CI</i>: 1.000-1.013, <i>p</i> = 0.043), and history of pre-pregnancy hypertension (<i>OR</i> = 13.51, 95% <i>CI</i>: 2.065-88.36, <i>p</i> = 0.007) as independent risk factors for CANO. Conversely, gestational age at delivery (<i>OR</i> = 0.727, 95% <i>CI</i>: 0.621-0.852, <i>p</i> < 0.001) was a protective factor. The sFlt-1/PlGF ratio predicted CANO with an AUC of 0.799 (95% <i>CI</i>: 0.743-0.855). The integrated nomogram model achieved a C-index of 0.880 (95% <i>CI</i>: 0.836-0.923), indicating excellent discrimination.</p><p><strong>Conclusion: </strong>The second-trimester sFlt-1/PlGF ratio is an independent predictor for CANO in PE. A model incorporating this biomarker facilitates the early identification of high-risk neonates, informing personalized perinatal management.</p>","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"39 1","pages":"2638630"},"PeriodicalIF":1.6,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147516023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-12-01Epub Date: 2026-03-05DOI: 10.1080/14767058.2026.2637209
V Habraken, D A A van der Woude, K Houthoff-Khemlani, W K G Leclercq, H J Niemarkt, J O E H van Laar
Introduction: Pregnancy after bariatric surgery is a high-risk pregnancy. Post-bariatric complications may require emergency surgical intervention. During laparoscopic surgery, anesthetic drugs and formation of pneumoperitoneum influence maternal hemodynamics and may impair the perfusion of the utero-placental unit. Subsequent changes of the fetal heart rate (FHR) might be recognized with intra-operative fetal monitoring and guide maternal positioning and hemodynamic management to maintain fetal wellbeing. However, current fetal monitoring guidelines do not include FHR interpretation during general anesthesia. Furthermore, FHR registration using conventional cardiotocogram (CTG) may be technically difficult due to surgically induced pneumoperitoneum. We developed a multidisciplinary local standard operating procedure based on current literature and guidelines. Intra-operative fetal monitoring using conventional CTG was implemented during laparoscopic surgery for suspected complication after bariatric surgery. We aim to establish whether FHR monitoring during laparoscopy is technically feasible. Secondary, we aim to establish a guideline for interpretation of intra-operative FHR during surgery.
Methods and analysis: Prospective, observational, feasibility study in a tertiary care hospital with a national referral function for post-bariatric complications in pregnancy. We will collect data from pregnant women with a gestational age of ≥ 24 weeks with a suspicion of a complication after bariatric surgery requiring surgical exploration. Non-Dutch speaking women and women with multiple gestation will be excluded. Data will be collected in Research Manager and analyzed using IBM SPSS Statistics for Windows, version 22.
Discussion: The available literature on intra-operative fetal monitoring is scarce. However, despite ambiguity in current international guidelines FHR monitoring is performed in various clinics. To avoid unnecessary caesareans during surgery it is important that FHR monitoring is of sufficient registration quality and that there are guidelines for interpretation of CTG during general anesthesia. However, the technique of intra-operative CTG has not been validated and hence the relevance of our standard operating procedure on intra-operative fetal monitoring during surgery for complications after bariatric surgery.
{"title":"Intra-operative fetal monitoring during non-obstetric surgery for complications after bariatric surgery: a standard operating procedure.","authors":"V Habraken, D A A van der Woude, K Houthoff-Khemlani, W K G Leclercq, H J Niemarkt, J O E H van Laar","doi":"10.1080/14767058.2026.2637209","DOIUrl":"10.1080/14767058.2026.2637209","url":null,"abstract":"<p><strong>Introduction: </strong>Pregnancy after bariatric surgery is a high-risk pregnancy. Post-bariatric complications may require emergency surgical intervention. During laparoscopic surgery, anesthetic drugs and formation of pneumoperitoneum influence maternal hemodynamics and may impair the perfusion of the utero-placental unit. Subsequent changes of the fetal heart rate (FHR) might be recognized with intra-operative fetal monitoring and guide maternal positioning and hemodynamic management to maintain fetal wellbeing. However, current fetal monitoring guidelines do not include FHR interpretation during general anesthesia. Furthermore, FHR registration using conventional cardiotocogram (CTG) may be technically difficult due to surgically induced pneumoperitoneum. We developed a multidisciplinary local standard operating procedure based on current literature and guidelines. Intra-operative fetal monitoring using conventional CTG was implemented during laparoscopic surgery for suspected complication after bariatric surgery. We aim to establish whether FHR monitoring during laparoscopy is technically feasible. Secondary, we aim to establish a guideline for interpretation of intra-operative FHR during surgery.</p><p><strong>Methods and analysis: </strong>Prospective, observational, feasibility study in a tertiary care hospital with a national referral function for post-bariatric complications in pregnancy. We will collect data from pregnant women with a gestational age of ≥ 24 weeks with a suspicion of a complication after bariatric surgery requiring surgical exploration. Non-Dutch speaking women and women with multiple gestation will be excluded. Data will be collected in Research Manager and analyzed using IBM SPSS Statistics for Windows, version 22.</p><p><strong>Discussion: </strong>The available literature on intra-operative fetal monitoring is scarce. However, despite ambiguity in current international guidelines FHR monitoring is performed in various clinics. To avoid unnecessary caesareans during surgery it is important that FHR monitoring is of sufficient registration quality and that there are guidelines for interpretation of CTG during general anesthesia. However, the technique of intra-operative CTG has not been validated and hence the relevance of our standard operating procedure on intra-operative fetal monitoring during surgery for complications after bariatric surgery.</p>","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"39 1","pages":"2637209"},"PeriodicalIF":1.6,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147366889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-12-01Epub Date: 2026-01-15DOI: 10.1080/14767058.2026.2614186
Wenmei Chen, Xiaotong Tang, Lizhou Sun, Dan Wu, Yuanyuan Zhang
Objective: To investigate maternal and neonatal outcomes and influencing factors in pregnant women with borderline hypertension.
Methods: This prospective cohort study consecutively enrolled 600 pregnant women receiving prenatal care at two hospitals between January 1 and December 31, 2024. Participants were divided into a normotensive control group (n = 300) and a borderline hypertension group (systolic 130-139 mmHg and/or diastolic 80-89 mmHg, n = 300). The primary outcome was progression to hypertensive disorders of pregnancy (HDP). Maternal and neonatal outcomes were compared, and influencing factors were analyzed.
Results: Women with borderline hypertension exhibited significantly higher rates of cesarean delivery (63.0% vs. 42.0%; p < 0.001), HDP progression (27.0% vs. 0.0%; p < 0.001), fetal growth restriction (15.7% vs. 2.7%; p < 0.001), and NICU admission (13.7% vs. 4.0%; p < 0.001) compared to normotensive controls. Notably, later gestational age at onset of borderline hypertension was identified as a protective factor against HDP progression (OR = 0.785 per week; 95% CI: 0.724-0.851; p < 0.001), corresponding to a 21.5% risk reduction for each delayed week of onset.
Conclusion: Borderline hypertension is associated with markedly increased adverse perinatal outcomes. Early detection and intervention-especially for women developing borderline elevation before 20 weeks-may help mitigate HDP progression. Integrating blood pressure trajectory monitoring into routine prenatal care is recommended.
目的:探讨交界性高血压孕妇的母婴结局及影响因素。方法:本前瞻性队列研究纳入了2024年1月1日至12月31日在两家医院接受产前护理的600名孕妇。参与者被分为正常血压对照组(n = 300)和临界高血压组(收缩压130- 139mmhg和/或舒张压80- 89mmhg, n = 300)。主要结局是进展为妊娠期高血压疾病(HDP)。比较产妇和新生儿的结局,并分析影响因素。结果:交界性高血压妇女的剖宫产率显著增高(63.0% vs 42.0%); p p p p p结论:交界性高血压与围产期不良结局显著增加相关。早期发现和干预,特别是对20周前出现边缘性增高的妇女,可能有助于缓解HDP的进展。建议将血压轨迹监测纳入常规产前护理。
{"title":"A prospective study on maternal and neonatal outcomes and influencing factors in pregnant women with borderline hypertension.","authors":"Wenmei Chen, Xiaotong Tang, Lizhou Sun, Dan Wu, Yuanyuan Zhang","doi":"10.1080/14767058.2026.2614186","DOIUrl":"https://doi.org/10.1080/14767058.2026.2614186","url":null,"abstract":"<p><strong>Objective: </strong>To investigate maternal and neonatal outcomes and influencing factors in pregnant women with borderline hypertension.</p><p><strong>Methods: </strong>This prospective cohort study consecutively enrolled 600 pregnant women receiving prenatal care at two hospitals between January 1 and December 31, 2024. Participants were divided into a normotensive control group (<i>n</i> = 300) and a borderline hypertension group (systolic 130-139 mmHg and/or diastolic 80-89 mmHg, <i>n</i> = 300). The primary outcome was progression to hypertensive disorders of pregnancy (HDP). Maternal and neonatal outcomes were compared, and influencing factors were analyzed.</p><p><strong>Results: </strong>Women with borderline hypertension exhibited significantly higher rates of cesarean delivery (63.0% vs. 42.0%; <i>p</i> < 0.001), HDP progression (27.0% vs. 0.0%; <i>p</i> < 0.001), fetal growth restriction (15.7% vs. 2.7%; <i>p</i> < 0.001), and NICU admission (13.7% vs. 4.0%; <i>p</i> < 0.001) compared to normotensive controls. Notably, later gestational age at onset of borderline hypertension was identified as a protective factor against HDP progression (OR = 0.785 per week; 95% CI: 0.724-0.851; <i>p</i> < 0.001), corresponding to a 21.5% risk reduction for each delayed week of onset.</p><p><strong>Conclusion: </strong>Borderline hypertension is associated with markedly increased adverse perinatal outcomes. Early detection and intervention-especially for women developing borderline elevation before 20 weeks-may help mitigate HDP progression. Integrating blood pressure trajectory monitoring into routine prenatal care is recommended.</p>","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"39 1","pages":"2614186"},"PeriodicalIF":1.6,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145991234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-12-01Epub Date: 2026-01-21DOI: 10.1080/14767058.2026.2617534
{"title":"Statement of Retraction: Low-dose vaginal misoprostol in the management of intrauterine fetal death.","authors":"","doi":"10.1080/14767058.2026.2617534","DOIUrl":"https://doi.org/10.1080/14767058.2026.2617534","url":null,"abstract":"","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"39 1","pages":"2617534"},"PeriodicalIF":1.6,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146020473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-12-01Epub Date: 2026-02-25DOI: 10.1080/14767058.2026.2636360
Maria Vc Gaitero, Ticiana Aa Mira, Edna Jl Gondim, Andrea V Gonçalves, Simony L Nascimento, Fernanda G Surita
Background: During the immediate postpartum period, breastfeeding could be challenge for many women due nipple pain and trauma. Non-pharmacological therapeutic strategies that reduce pain and accelerate healing are essential to prevent early weaning and support successful lactation.
Objective: This study aimed to evaluate the effectiveness of low-level laser therapy (LLLT) in reducing pain and promoting healing of nipple trauma in postpartum women, as well as to assess participants satisfaction with the intervention.
Methods: This multicentric, controlled, randomized, double-blind clinical trial included 60 women equally divided into an experimental group (2 J of red light at the nipple's central point and 4 J of infrared light in a cross pattern over the areolar region) and a sham group. Pain intensity was measured using the Numeric Rating Scale before, during, and up to 7 days after the intervention, and healing was assessed using a validated instrument. Intention-to-treat analysis was conducted.
Results: We found a significant reduction in pain in the experimental group, with relief observed 30 min (p = 0.0439) after the LLLT application. Pain diary analyses indicated that, compared to the sham group, the experimental group reported lower pain intensity at 1h (p = 0.0485), 6h (p = 0.0194), 12h (p = 0.0033), and 7 days after the intervention (p = 0.0085). There was no significant difference in the level of satisfaction between groups (p = 0.652), and no adverse effects were identified.
Conclusion: LLLT proved to be a safe, effective, and feasible approach for managing pain associated with nipple trauma in the early postpartum, providing maternal comfort and supporting the continuation of exclusive breastfeeding.
{"title":"Low-level laser therapy for breastfeeding women with nipple pain in the early postpartum period: a randomized controlled trial.","authors":"Maria Vc Gaitero, Ticiana Aa Mira, Edna Jl Gondim, Andrea V Gonçalves, Simony L Nascimento, Fernanda G Surita","doi":"10.1080/14767058.2026.2636360","DOIUrl":"https://doi.org/10.1080/14767058.2026.2636360","url":null,"abstract":"<p><strong>Background: </strong>During the immediate postpartum period, breastfeeding could be challenge for many women due nipple pain and trauma. Non-pharmacological therapeutic strategies that reduce pain and accelerate healing are essential to prevent early weaning and support successful lactation.</p><p><strong>Objective: </strong>This study aimed to evaluate the effectiveness of low-level laser therapy (LLLT) in reducing pain and promoting healing of nipple trauma in postpartum women, as well as to assess participants satisfaction with the intervention.</p><p><strong>Methods: </strong>This multicentric, controlled, randomized, double-blind clinical trial included 60 women equally divided into an experimental group (2 J of red light at the nipple's central point and 4 J of infrared light in a cross pattern over the areolar region) and a sham group. Pain intensity was measured using the Numeric Rating Scale before, during, and up to 7 days after the intervention, and healing was assessed using a validated instrument. Intention-to-treat analysis was conducted.</p><p><strong>Results: </strong>We found a significant reduction in pain in the experimental group, with relief observed 30 min (<i>p</i> = 0.0439) after the LLLT application. Pain diary analyses indicated that, compared to the sham group, the experimental group reported lower pain intensity at 1h (<i>p</i> = 0.0485), 6h (<i>p</i> = 0.0194), 12h (<i>p</i> = 0.0033), and 7 days after the intervention (<i>p</i> = 0.0085). There was no significant difference in the level of satisfaction between groups (<i>p</i> = 0.652), and no adverse effects were identified.</p><p><strong>Conclusion: </strong>LLLT proved to be a safe, effective, and feasible approach for managing pain associated with nipple trauma in the early postpartum, providing maternal comfort and supporting the continuation of exclusive breastfeeding.</p>","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"39 1","pages":"2636360"},"PeriodicalIF":1.6,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147311984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-12-01Epub Date: 2026-01-14DOI: 10.1080/14767058.2025.2612451
Edwin Chandraharan, Ilenia Mappa, Anna Gracia Perez-Bonfils, Susana Pereira
Onset of uterine contractions which become progressively more frequent, intense and last for longer durations as the labor progresses is expected to cause a gradually evolving hypoxic stress to human fetuses. This is because of the repeated constriction of maternal spiral arterioles supplying the placental bed and compression of the umbilical cord as the labor advances. The majority of fetuses are able to mount physiological compensatory responses to protect their high priority central organs by maintaining aerobic metabolism. However, fetuses who are exposed to preexisting compromise such as chronic utero-placental insufficiency, chorioamnionitis or chronic fetal anemia and acidosis may not have sufficient reserves to withstand further hypoxic stress, leading to rapid decompensation and neurological injury or death. Physiological interpretation of fetal heart rate changes involves recognition of specific features of both hypoxic and non-hypoxic stresses on the cardiotocograph (CTG) and determining the fetal compensatory responses to ongoing stress. This approach which is based on the cardinal principle of individualization of care will enable frontline clinicians to differentiate features of compensation from decompensation. Timely interventions to improve intrauterine environment and/or to accomplish urgent birth will help avoid hypoxic ischemic encephalopathy (HIE) and its long term sequalae (cerebral palsy or learning difficulties) and perinatal deaths. Conversely, continuation of labor with careful observation in fetuses with compensated gradually evolving hypoxic stress will help avoid unnecessary intrapartum operative interventions. Emerging evidence suggests reduction in the rates of both HIE and emergency cesarean sections following the implementation of principles of physiological interpretation of CTG.
{"title":"Implementation of physiological interpretation of fetal heart rate changes: from scientific principles to frontline practice.","authors":"Edwin Chandraharan, Ilenia Mappa, Anna Gracia Perez-Bonfils, Susana Pereira","doi":"10.1080/14767058.2025.2612451","DOIUrl":"https://doi.org/10.1080/14767058.2025.2612451","url":null,"abstract":"<p><p>Onset of uterine contractions which become progressively more frequent, intense and last for longer durations as the labor progresses is expected to cause a gradually evolving hypoxic stress to human fetuses. This is because of the repeated constriction of maternal spiral arterioles supplying the placental bed and compression of the umbilical cord as the labor advances. The majority of fetuses are able to mount physiological compensatory responses to protect their high priority central organs by maintaining aerobic metabolism. However, fetuses who are exposed to preexisting compromise such as chronic utero-placental insufficiency, chorioamnionitis or chronic fetal anemia and acidosis may not have sufficient reserves to withstand further hypoxic stress, leading to rapid decompensation and neurological injury or death. Physiological interpretation of fetal heart rate changes involves recognition of specific features of both hypoxic and non-hypoxic stresses on the cardiotocograph (CTG) and determining the fetal compensatory responses to ongoing stress. This approach which is based on the cardinal principle of individualization of care will enable frontline clinicians to differentiate features of compensation from decompensation. Timely interventions to improve intrauterine environment and/or to accomplish urgent birth will help avoid hypoxic ischemic encephalopathy (HIE) and its long term sequalae (cerebral palsy or learning difficulties) and perinatal deaths. Conversely, continuation of labor with careful observation in fetuses with compensated gradually evolving hypoxic stress will help avoid unnecessary intrapartum operative interventions. Emerging evidence suggests reduction in the rates of both HIE and emergency cesarean sections following the implementation of principles of physiological interpretation of CTG.</p>","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"39 1","pages":"2612451"},"PeriodicalIF":1.6,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145985619","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-12-01Epub Date: 2026-01-25DOI: 10.1080/14767058.2026.2616104
Xiuying Chen, Linna Jin, Baihui Zhao
<p><strong>Objective: </strong>To report a case of transient conductive hearing loss secondary to secretory otitis media (SOM) in a patient with preeclampsia, highlight its unique pathophysiological link, and emphasize the importance of recognizing this potential complication.</p><p><strong>Case presentation: </strong>Preeclampsia is a severe, pregnancy-specific multisystem disorder characterized by new-onset hypertension and proteinuria after 20 weeks of gestation. While endothelial dysfunction and vasospasm are central to its pathophysiology, its clinical manifestations are diverse. Auditory dysfunction, particularly conductive hearing loss, is infrequently reported. We present a case of a 25-year-old gravida 2, para 0 woman diagnosed with preeclampsia at 33 weeks of gestation. She had persistent proteinuria (24-hour urinary protein 1244.7 mg), unstable hypertension (148-165/95-107mmHg) managed with labetalol (100 mg every 8 h, suboptimal adherence), and gestational diabetes. She had no prior history of ear disease, trauma, or ototoxic medication use.At 35w5d gestation, the patient developed sudden bilateral hearing loss, accompanied by mild chest tightness and an elevated brain natriuretic peptide (BNP) level (346.1 pg/ml). Otolaryngology consultation was performed, and otoendoscopic examination revealed bilateral intratympanic fluid. Pure tone audiometry confirmed bilateral conductive hearing loss with significant air-bone gaps (left 30 dB, right 13 dB). Bone conduction thresholds were within normal limits (left 15 dB, right 16 dB), ruling out sensorineural hearing loss. Acoustic immittance audiometry showed bilateral B-type tympanograms, indicative of middle ear effusion. Alternative causes of conductive hearing loss (e.g. upper respiratory infection-related eustachian tube dysfunction, barotrauma, tympanic membrane pathology, middle ear mass) were excluded through clinical evaluation, negative inflammatory markers (C-reactive protein: <0.5 mg/l, white blood cell count: 12.9 × 10^9), and absence of relevant symptoms. Given her deteriorating condition, an emergent Cesarean section was performed at 36 weeks of gestation, delivering a healthy male infant. Postoperatively, supportive management with combined diuretics (furosemide and spironolactone) led to rapid and complete resolution of her hearing deficits within three days. She was discharged on continued antihypertensive therapy and was well at one-month follow-up.</p><p><strong>Conclusion: </strong>Transient conductive hearing loss due to SOM is a rare manifestation of preeclampsia, likely driven by hypertension-induced increased vascular permeability and altered fluid dynamics. Severe proteinuria may exacerbate systemic fluid imbalance, contributing to middle ear effusion. Early recognition <i>via</i> audiometric and tympanometric evaluation, exclusion of alternative etiologies, and targeted management (e.g. fluid overload reduction) can ensure prompt recovery and improve maternal outcome
{"title":"Transient conductive hearing loss as a notable and rare manifestation of preeclampsia: a case report.","authors":"Xiuying Chen, Linna Jin, Baihui Zhao","doi":"10.1080/14767058.2026.2616104","DOIUrl":"https://doi.org/10.1080/14767058.2026.2616104","url":null,"abstract":"<p><strong>Objective: </strong>To report a case of transient conductive hearing loss secondary to secretory otitis media (SOM) in a patient with preeclampsia, highlight its unique pathophysiological link, and emphasize the importance of recognizing this potential complication.</p><p><strong>Case presentation: </strong>Preeclampsia is a severe, pregnancy-specific multisystem disorder characterized by new-onset hypertension and proteinuria after 20 weeks of gestation. While endothelial dysfunction and vasospasm are central to its pathophysiology, its clinical manifestations are diverse. Auditory dysfunction, particularly conductive hearing loss, is infrequently reported. We present a case of a 25-year-old gravida 2, para 0 woman diagnosed with preeclampsia at 33 weeks of gestation. She had persistent proteinuria (24-hour urinary protein 1244.7 mg), unstable hypertension (148-165/95-107mmHg) managed with labetalol (100 mg every 8 h, suboptimal adherence), and gestational diabetes. She had no prior history of ear disease, trauma, or ototoxic medication use.At 35w5d gestation, the patient developed sudden bilateral hearing loss, accompanied by mild chest tightness and an elevated brain natriuretic peptide (BNP) level (346.1 pg/ml). Otolaryngology consultation was performed, and otoendoscopic examination revealed bilateral intratympanic fluid. Pure tone audiometry confirmed bilateral conductive hearing loss with significant air-bone gaps (left 30 dB, right 13 dB). Bone conduction thresholds were within normal limits (left 15 dB, right 16 dB), ruling out sensorineural hearing loss. Acoustic immittance audiometry showed bilateral B-type tympanograms, indicative of middle ear effusion. Alternative causes of conductive hearing loss (e.g. upper respiratory infection-related eustachian tube dysfunction, barotrauma, tympanic membrane pathology, middle ear mass) were excluded through clinical evaluation, negative inflammatory markers (C-reactive protein: <0.5 mg/l, white blood cell count: 12.9 × 10^9), and absence of relevant symptoms. Given her deteriorating condition, an emergent Cesarean section was performed at 36 weeks of gestation, delivering a healthy male infant. Postoperatively, supportive management with combined diuretics (furosemide and spironolactone) led to rapid and complete resolution of her hearing deficits within three days. She was discharged on continued antihypertensive therapy and was well at one-month follow-up.</p><p><strong>Conclusion: </strong>Transient conductive hearing loss due to SOM is a rare manifestation of preeclampsia, likely driven by hypertension-induced increased vascular permeability and altered fluid dynamics. Severe proteinuria may exacerbate systemic fluid imbalance, contributing to middle ear effusion. Early recognition <i>via</i> audiometric and tympanometric evaluation, exclusion of alternative etiologies, and targeted management (e.g. fluid overload reduction) can ensure prompt recovery and improve maternal outcome","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"39 1","pages":"2616104"},"PeriodicalIF":1.6,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146047291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-12-01Epub Date: 2026-02-15DOI: 10.1080/14767058.2026.2629687
Maria Söröd, Erika Gyllencreutz
Introduction: Cardiotocography (CTG) is used for fetal surveillance to prevent asphyxia related neonatal outcomes during pregnancy and delivery. In Sweden, all delivery wards have transitioned from CTG registered and printed on paper inside the delivery room, to digital central fetal monitoring where CTG is visible both in the delivery room and on distance for multiple observers. We aimed to evaluate whether the transition from CTG on paper to central fetal monitoring has affected neonatal morbidity.
Material and methods: The study was conducted as a retrospective cohort study. Data from 8577 deliveries in Östersund, Sweden were extracted from medical records. The study population was divided into two cohorts, one where the CTG registration during delivery had been printed on paper (Cohort I, January 2012-December 2015), and one where digital central fetal monitoring was used (Cohort II, July 2016-December 2019). The cohorts were compared regarding the incidence of neonatal metabolic acidosis (umbilical artery pH <7.05 and base deficit >12 mmol/L) as the main outcome, and secondary outcomes such as Apgar score at 5 min of age, the incidence of neonatal resuscitation, and the incidence of emergency cesarean and instrumental vaginal birth due to suspected fetal hypoxia.
Results: The incidence of metabolic acidosis was 0.5% in Cohort I and 0.6% in Cohort II, odds ratio (OR) 1.27, 95% confidence interval (CI) 0.67-2.40, p = 0.46. There were no statistically significant differences in any of the secondary neonatal outcomes. Adjustment for potential confounders did not alter the estimates. The cohorts differed in the incidence of inductions of labor; 18.8% in Cohort I vs 23.2% in Cohort II, p < 0.0001, and the use of oxytocin; 50.2% vs 60.0%, p < 0.0001, both of which were more frequent in Cohort II. The incidence of instrumental vaginal births due to suspected fetal hypoxia was lower in the cohort with digital CTG; 3.6% vs 2.6%, p = 0.01.
Conclusion: We observed no difference regarding the incidence of neonatal metabolic acidosis or other neonatal outcomes between the cohort that had CTG registered and printed on paper, and the cohort with digital central fetal monitoring.
心脏造影(CTG)用于胎儿监测,以防止在怀孕和分娩期间窒息相关的新生儿结局。在瑞典,所有产房都已从CTG登记并打印在产房内的纸上,过渡到数字中心胎儿监测,在产房内和多个观察者都可以看到CTG。我们的目的是评估从纸面CTG到中心胎儿监测的转变是否影响了新生儿的发病率。材料和方法:本研究采用回顾性队列研究。从医疗记录中提取瑞典Östersund的8577例分娩数据。研究人群分为两组,一组使用纸质打印分娩期间CTG登记(队列1,2012年1月至2015年12月),另一组使用数字中心胎儿监测(队列2,2016年7月至2019年12月)。比较两组以新生儿代谢性酸中毒发生率(脐动脉pH为12 mmol/L)为主要结局,以及5 min时Apgar评分、新生儿复苏发生率、疑似胎儿缺氧导致的紧急剖宫产和顺产发生率等次要结局。结果:队列1代谢性酸中毒发生率为0.5%,队列2为0.6%,优势比(OR) 1.27, 95%可信区间(CI) 0.67 ~ 2.40, p = 0.46。在新生儿的继发性结局方面没有统计学上的显著差异。对潜在混杂因素的调整没有改变估计。两组在引产发生率上存在差异;队列I为18.8%,队列II为23.2%,p p p = 0.01。结论:我们观察到,在新生儿代谢性酸中毒的发生率和其他新生儿结局方面,CTG登记并打印在纸上的队列与数字中心胎儿监测队列没有差异。
{"title":"Introduction of central fetal monitoring and impact on neonatal outcome - a retrospective observational cohort study.","authors":"Maria Söröd, Erika Gyllencreutz","doi":"10.1080/14767058.2026.2629687","DOIUrl":"https://doi.org/10.1080/14767058.2026.2629687","url":null,"abstract":"<p><strong>Introduction: </strong>Cardiotocography (CTG) is used for fetal surveillance to prevent asphyxia related neonatal outcomes during pregnancy and delivery. In Sweden, all delivery wards have transitioned from CTG registered and printed on paper inside the delivery room, to digital central fetal monitoring where CTG is visible both in the delivery room and on distance for multiple observers. We aimed to evaluate whether the transition from CTG on paper to central fetal monitoring has affected neonatal morbidity.</p><p><strong>Material and methods: </strong>The study was conducted as a retrospective cohort study. Data from 8577 deliveries in Östersund, Sweden were extracted from medical records. The study population was divided into two cohorts, one where the CTG registration during delivery had been printed on paper (Cohort I, January 2012-December 2015), and one where digital central fetal monitoring was used (Cohort II, July 2016-December 2019). The cohorts were compared regarding the incidence of neonatal metabolic acidosis (umbilical artery pH <7.05 and base deficit >12 mmol/L) as the main outcome, and secondary outcomes such as Apgar score at 5 min of age, the incidence of neonatal resuscitation, and the incidence of emergency cesarean and instrumental vaginal birth due to suspected fetal hypoxia.</p><p><strong>Results: </strong>The incidence of metabolic acidosis was 0.5% in Cohort I and 0.6% in Cohort II, odds ratio (OR) 1.27, 95% confidence interval (CI) 0.67-2.40, <i>p</i> = 0.46. There were no statistically significant differences in any of the secondary neonatal outcomes. Adjustment for potential confounders did not alter the estimates. The cohorts differed in the incidence of inductions of labor; 18.8% in Cohort I vs 23.2% in Cohort II, <i>p</i> < 0.0001, and the use of oxytocin; 50.2% vs 60.0%, <i>p</i> < 0.0001, both of which were more frequent in Cohort II. The incidence of instrumental vaginal births due to suspected fetal hypoxia was lower in the cohort with digital CTG; 3.6% vs 2.6%, <i>p</i> = 0.01.</p><p><strong>Conclusion: </strong>We observed no difference regarding the incidence of neonatal metabolic acidosis or other neonatal outcomes between the cohort that had CTG registered and printed on paper, and the cohort with digital central fetal monitoring.</p>","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"39 1","pages":"2629687"},"PeriodicalIF":1.6,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146203602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}